Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Alcohol consumption and lung cancer risk in never smokers: a pooled analysis of case-control studies.

García Lavandeira JA, Ruano-Ravina A, Kelsey KT, Torres-Durán M, Parente-Lamelas I, Leiro-Fernández V, Zapata M, Abal-Arca J, Vidal-García I, Montero-Martínez C, Amenedo M, Castro-Añón O, Golpe-Gómez A, Guzmán-Taveras R, Martínez C, Provencio M, Mejuto-Martí MJ, García-García S, Fernández-Villar A, Piñeiro M, Barros-Dios JM.

Eur J Public Health. 2018 Jun 1;28(3):521-527. doi: 10.1093/eurpub/ckx196.

PMID:
29140412
2.

Environmental tobacco smoke exposure and EGFR and ALK alterations in never smokers' lung cancer. Results from the LCRINS study.

Torres-Durán M, Ruano-Ravina A, Kelsey KT, Parente-Lamelas I, Leiro-Fernández V, Abdulkader I, Provencio M, Abal-Arca J, Castro-Añón O, Montero-Martínez C, Vidal-García I, Amenedo M, Golpe-Gómez A, Martínez C, Guzmán-Taveras R, Mejuto-Martí MJ, Fernández-Villar A, Barros-Dios JM.

Cancer Lett. 2017 Dec 28;411:130-135. doi: 10.1016/j.canlet.2017.09.042. Epub 2017 Oct 5.

PMID:
28987389
3.

Small Cell Lung Cancer. Methodology and Preliminary Results of the SMALL CELL Study.

Rodríguez-Martínez Á, Ruano-Ravina A, Torres-Durán M, Vidal-García I, Leiro-Fernández V, Hernández-Hernández J, García-García S, Provencio M, Castro-Añón O, Parente-Lamelas I, Abdulkader I, Abal-Arca J, Montero-Martínez C, Amenedo M, Guzmán-Taveras R, Fernández-Villar A, Barros-Dios JM.

Arch Bronconeumol. 2017 Dec;53(12):675-681. doi: 10.1016/j.arbres.2017.04.016. Epub 2017 Jun 15. English, Spanish.

4.

Residential radon, EGFR mutations and ALK alterations in never-smoking lung cancer cases.

Ruano-Ravina A, Torres-Durán M, Kelsey KT, Parente-Lamelas I, Leiro-Fernández V, Abdulkader I, Abal-Arca J, Montero-Martínez C, Vidal-García I, Amenedo M, Castro-Añón O, Golpe-Gómez A, González-Barcala J, Martínez C, Guzmán-Taveras R, Provencio M, Mejuto-Martí MJ, Fernández-Villar A, Barros-Dios JM.

Eur Respir J. 2016 Nov;48(5):1462-1470. doi: 10.1183/13993003.00407-2016. Epub 2016 Oct 6.

5.

Fluorescence in situ hybridization analysis of the ALK gene in 2,045 non-small cell lung cancer patients from North-Western Spain (Galicia).

Sánchez-Ares M, Cameselle-Teijeiro JM, Vázquez-Estévez S, Lázaro-Quintela M, Vázquez-Boquete Á, Afonso-Afonso FJ, Casal-Rubio J, González-Piñeiro AL, Rico-Rodríguez Y, Fírvida-Pérez JL, Ruíz-Bañobre J, Couso E, Santomé L, Pérez-Becerra R, García-Campelo R, Amenedo M, Azpitarte-Raposeiras C, Antúnez J, Abdulkader I.

Oncol Lett. 2016 Aug;12(2):1403-1407. Epub 2016 Jun 28.

6.

EGFR testing and clinical management of advanced NSCLC: a Galician Lung Cancer Group study (GGCP 048-10).

Vázquez S, Casal J, Afonso Afonso FJ, Fírvida JL, Santomé L, Barón F, Lázaro M, Pena C, Amenedo M, Abdulkader I, González-Arenas C, Fachal L, Vega A.

Cancer Manag Res. 2016 Feb 4;8:11-20. doi: 10.2147/CMAR.S85173. eCollection 2016.

7.

Choriocarcinoma syndrome.

Medina A, Ramos M, Amenedo M, París L.

Arch Esp Urol. 2014 Oct;67(8):711-4. English, Spanish.

PMID:
25306991
8.

Second-line treatment in advanced non-small-cell lung cancer in the epidermal growth factor receptor wild-type population: review of patient profile.

Vázquez S, Lázaro M, Fírvida JL, Santomé L, Afonso J, Amenedo M, Casal J; Galician Lung Cancer Group (GGCP).

Anticancer Drugs. 2014 Apr;25(4):368-74. doi: 10.1097/CAD.0000000000000066. Review.

PMID:
24384805
9.

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study.

Casal Rubio J, Fírvida-Pérez JL, Lázaro-Quintela M, Barón-Duarte FJ, Alonso-Jáudenes G, Santomé L, Afonso-Afonso FJ, Amenedo M, Huidobro G, Campos-Balea B, López-Vázquez MD, Vázquez S.

Cancer Chemother Pharmacol. 2014 Mar;73(3):451-7. doi: 10.1007/s00280-013-2370-z. Epub 2013 Dec 19.

PMID:
24352251
10.

First-line bevacizumab, cisplatin and vinorelbine plus maintenance bevacizumab in advanced non-squamous non-small cell lung cancer chemo-naïve patients.

Leon L, Vázquez S, Gracia JM, Casal J, Lazaro M, Firvida JL, Amenedo M, Santome L, Macia S.

Expert Opin Pharmacother. 2012 Jul;13(10):1389-96. doi: 10.1517/14656566.2012.693165. Epub 2012 May 25.

PMID:
22630129
11.

Evaluation of fetal nuchal translucency in 98 pregnancies at risk for severe spinal muscular atrophy: possible relevance of the SMN2 copy number.

Parra J, Alias L, Also-Rallo E, Martínez-Hernández R, Senosiain R, Medina C, Alejos O, Rams N, Amenedo M, Ormo F, Jesús Barceló M, Calaf J, Baiget M, Bernal S, Tizzano EF.

J Matern Fetal Neonatal Med. 2012 Aug;25(8):1246-9. doi: 10.3109/14767058.2011.636101. Epub 2011 Nov 30.

PMID:
22082206
12.

Ultrasound evaluation of fetal movements in pregnancies at risk for severe spinal muscular atrophy.

Parra J, Martínez-Hernández R, Also-Rallo E, Alias L, Barceló MJ, Amenedo M, Medina C, Senosiain R, Calaf J, Baiget M, Bernal S, Tizzano EF.

Neuromuscul Disord. 2011 Feb;21(2):97-101. doi: 10.1016/j.nmd.2010.09.010. Epub 2010 Dec 30.

PMID:
21194946
13.

A phase II randomized trial of gemcitabine-docetaxel versus gemcitabine-cisplatin in patients with advanced non-small cell lung carcinoma.

Rubio JC, Vázquez S, Vázquez F, Amenedo M, Fírvida JL, Mel JR, Huidobro G, Alvarez E, Lázaro M, Alonso G, Fernández I; Galician Group of Lung Cancer (GGCP in the Spanish acronym).

Cancer Chemother Pharmacol. 2009 Jul;64(2):379-84. doi: 10.1007/s00280-008-0884-6. Epub 2009 Jan 13.

PMID:
19139896
14.

Biweekly administration of docetaxel and vinorelbine as second-line chemotherapy for patients with stage IIIB and IV non-small cell lung cancer: a phase II study of the Galician Lung Cancer Group (GGCP 013-02).

Vázquez S, Huidobro G, Amenedo M, Fírvida JL, León L, Lázaro M, Grande C, Mel JR, Ramos M, Salgado M, Casal J.

Anticancer Drugs. 2007 Nov;18(10):1201-6.

PMID:
17893521
15.

Evidence of a segregation ratio distortion of SMN1 alleles in spinal muscular atrophy.

Alias L, Barceló MJ, Gich I, Estapé M, Parra J, Amenedo M, Baiget M, Tizzano EF.

Eur J Hum Genet. 2007 Oct;15(10):1090-3. Epub 2007 Jul 11.

16.

Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: a lung cancer Galician group phase II study.

Casal J, Amenedo M, Mel JR, Antón LM, Rodríguez-López R, López-López R, González-Ageitos A, Castellanos J, Constenla M, Tisaire JL.

Cancer Chemother Pharmacol. 2007 Oct;60(5):725-32. Epub 2007 Feb 2.

PMID:
17273825
17.

Docetaxel plus fractionated cisplatin is a safe and active schedule as first-line treatment of patients with advanced non-small cell lung cancer: results of a phase II study.

Firvida JL, Amenedo M, Rodríguez R, González A, Salgado M, Ramos M, Losada G.

Invest New Drugs. 2004 Nov;22(4):481-7.

PMID:
15292719
18.

Multicenter randomized trial comparing sequential with concomitant administration of doxorubicin and docetaxel as first-line treatment of metastatic breast cancer: a Spanish Breast Cancer Research Group (GEICAM-9903) phase III study.

Alba E, Martín M, Ramos M, Adrover E, Balil A, Jara C, Barnadas A, Fernández-Aramburo A, Sánchez-Rovira P, Amenedo M, Casado A; Spanish Breast Cancer Research Group.

J Clin Oncol. 2004 Jul 1;22(13):2587-93.

PMID:
15226326
19.

Biweekly docetaxel as second-line chemotherapy of patients with advanced non-small cell lung cancer: a phase II study of the Galician Lung Cancer Group (GGCP 006-00).

Vázquez S, Grande C, Amenedo M, Fírvida JL, Lázaro M, Alonso G, Curiel T, Huidobro G, Mel JR, Ramos M.

Anticancer Drugs. 2004 Jun;15(5):489-94.

PMID:
15166623
20.

A new successful therapy for fetal chylothorax by intrapleural injection of maternal blood.

Parra J, Amenedo M, Muñiz-Díaz E, Ormo F, Simó M, Vega C, Fernández JG, Senosiain R, Moliner E, Guinovart G.

Ultrasound Obstet Gynecol. 2003 Sep;22(3):290-4.

21.

Weekly docetaxel as second-line therapy for patients with advanced breast cancer resistant to previous anthracycline treatment.

Ramos M, González-Ageitos A, Amenedo M, González-Quintas A, Gamazo JL, Togores P, Losada G, Almanza C, Romero C, Gómez-Martín C.

J Chemother. 2003 Apr;15(2):192-7.

PMID:
12797398
22.

Gemcitabine, cisplatin and vinorelbine as induction chemotherapy followed by radical therapy in stage III non-small-cell lung cancer: a multicentre study of galician-lung-cancer-group.

León L, Cueva-Banuelos JF, Huidobro G, Fírvida JL, Amenedo M, Lázaro M, Romero C, Estévez SV, Barón FJ, Grande C, García Mata J, González A, Castellanos J, Gómez A, Caeiro M, Rodríguez MR, Casal J; Galician Lung Cancer Group.

Lung Cancer. 2003 May;40(2):215-20.

PMID:
12711124
23.

CHOP chemotherapy of intermediate and high-grade non-Hodgkin's lymphoma.

Llanos M, Tabernero J, Brunet J, Amenedo M, Pallares C, de Andres L, Lopez JJ.

Acta Oncol. 1994;33(8):935-9.

PMID:
7818928

Supplemental Content

Loading ...
Support Center